The rehabilitation clinic Zihlschlacht is a leading specialist clinic for neurologic rehabilitation. It provides excellent medical treatment, professional therapies and specialised care as well as an individual attendance which is based on humanity and respect. The clinic is specialized in treatment of brain and nerve damaged patients with the goal of reintegration into daily life. Humaine Zihlschlacht treats patients of all insurance classes and also offers a private station for patients with semi-private and private insurance.

All Hocoma products are used daily to support and enhance the rehabilitation of the patients at the Clinic Zihlschlacht. The devices form a "center for robot-assissted movement" and are fully integrated into the overall concept of rehabilitation. The close collaboration between Hocoma and the rehabilitation clinic Zihlschlacht allows to implement experiences of doctors and therapists into further developments of Hocoma products.

The Rehabilitation Institute of Chicago (RIC) is the nation’s #1 ranked provider of comprehensive physical medicine and rehabilitation care to patients from around the world and is the leader in research and development of the cutting-edge treatments and technologies in its field.  Through repair, regeneration and recovery of the brain, spinal cord and musculoskeletal system, RIC advances the ability of its patients to help them to achieve their goals and pursue their life’s passions.  

RIC holds an unparalleled market distinction with a record six federal research designations awarded and funded by the National Institutes of Health (NIH) and the Department of Education’s National Institute of Disability and Rehabilitation Research (NIDRR) in the areas of spinal cord injury, traumatic brain injury, stroke, neurological rehabilitation, outcomes research and rehabilitation engineering research. In fact, the ArmeoSpring has been developed together with researchers and physicians from RIC.

Shepherd Center, located in Atlanta, Ga., is a private, not-for-profit hospital specializing in medical treatment, research and rehabilitation for people with spinal cord injury or brain injury. Founded in 1975, Shepherd Center is ranked by U.S. News & World Report among the top 10 rehabilitation hospitals in the nation.
Shepherd Center offers a complete continuum of care, from evaluation and medical treatment to rehabilitation and lifelong support programs. Patients at Shepherd Center receive customized solutions to help them integrate daily tasks back into their lives. Experts and technology specialists help people customize an appropriate package of technological solutions that maximize independence in accomplishing day-to-day tasks

Shepherd Center is using the Lokomat system for clinical and research purposes and to further develop the understanding of most efficient rehabilitations solutions

Spaulding is a teaching hospital of Harvard Medical School as well as the official rehabilitation hospital of the New England Patriots. Spaulding is the only rehabilitation hospital in New England continually ranked since 1995 by U.S. News and World Report in its Best Hospitals survey. A center of research and innovation, Spaulding is home to over 100 active research studies including Parkinson's Disease, Cerebral Palsy and Traumatic Brain Injury.

In close collaboration between medical doctors, therapists, engineers and scientists from basic research, ideas and concepts for new therapy solutions for children and adults are developed and tested under laboratory conditions. Focuses of this collaboration are new treatment modalities for the upper extremities as well as advanced gait rehabilitation based on the Lokomat. This close collaboration with a multidisciplinary team covering clinical and engineering skills is a crucial success factor in early phase product development.

Tan Tock Seng Hospital champions the development of Geriatric Medicine, Infectious Disease Management, Rehabilitation Medicine, Respiratory Medicine, Rheumatology, Allergy & Immunology in Singapore. The hospital is a member of the National Healthcare group and continues to provide high quality holistic healthcare services to the people of Singapore.

The Tan Tock Seng Rehabilitation Centre is the largest and most established Rehab facility in Singapore  specialising in Stroke, Traumatic Brain Injury & Spinal Cord Inury Rehabilitation. Established in 1973, it has an excellent record of  helping  people with complex rehabilitation conditions  achieve maximal functional independence through comprehensive inpatient and outpatient rehabilitation programmes.

TTSH Rehabilitation Centre is Hocoma’s partner for research and development, and Lokomat training in the Asia Pacific region

The Center for outpatient Rehabilitation Zurich (ZAR) offers outpatient neurorehabilitation in an interdisciplinary context. Occupational therapists, physical therapists, speech therapists and neuropsychologists work closely together assuring that patients with neurological disorders receive rehabilitation in its entirety and close to their residence. Based on the close collaboration with Hocoma, the range of therapy solutions at ZAR was expanded with Lokomat, ArmeoSpring and ArmeoBoom. The combination of scientific-based therapy methods and modern technologies promises the best possible prospects in the treatment of patients with neurological disorders.

At ZAR modern technologies are used by skilled therapists for individual therapies and they are evaluated within research projects.

The fundamental development steps in the Lokomat system took place in the Rehabilitation and Research Centre of Balgrist University Hospital specialized in spinal cord injury. The further development of the Lokomat system is being attended together with clinical research at Balgrist University Hospital. In this way, there is a guarantee that the requirements and experience of the customers - i.e. the patients, therapists and hospitals - are included in the development.

ETH Zurich is a technical and scientific university with excellent international research reputation. ETH Zurich is place of study, research and work for over 20,000 people from 80 different nations. About 370 professorships in 16 departments are responsible for high-quality research and teaching in the fields of technical, mathematical and natural sciences.

Hocoma cooperates with the Sensory-Motor Systems Lab (SMS Lab) of the Institute of Robotics and Intelligent Systems (IRIS) in developing innovative technological solutions for rehabilitation. The SMS Lab is the scientific partner for research of patient-cooperative control strategies which are mainly used for Lokomat and ArmeoPower. In addition SMS Lab supports Hocoma in the advancement and clinical evaluation of robotic therapy solutions.

The Spinal Cord Injury Center at the Heidelberg University Hospital represents an internationally recognized institution for the in-patient and out-patient treatment of individuals suffering from spinal cord injury. Besides providing comprehensive care to traumatic as well as non-traumatic spinal cord injury patients, we have a strong focus in investigating novel therapeutic approaches to improve their quality of life and independence beyond the current state of the art.

A close cooperation with Hocoma exists since the company has been founded. The Heidelberg University Hospital has participated in the first clinical trial showing the efficacy of the Lokomat and contributed to the development of the Erigo and its clinical evaluation.

The mission of the Biorobotics Laboratory at U.C. Irvine is to develop robotic and mechatronic devices that transform human movement, motor learning, and rehabilitation. One focus is the development of cost-efficient devices that patients can use to exercise and optimize recovery on their own, based on a scientific understanding of neuromotor plasticity and motor learning. Directed by Prof. David Reinkensmeyer, the Biorobotics Laboratory developed the first prototype of the ArmeoSpring in close collaboration with the Rehabilitation Institute of Chicago (RIC) and Tariq Rahman of the Alfred I. duPont Hospital for Children.  Hocoma worked with U.C. Irvine to transfer the technology, resulting in the successful launch of the ArmeoSpring therapy system in 2007. Hocoma, U.C. Irvine, and RIC continue to collaborate to further enhance the ArmeoSpring therapy system.

The Rehabilitation Institute of Chicago (RIC) is the nation’s #1 ranked provider of comprehensive physical medicine and rehabilitation care to patients from around the world and is the leader in research and development of the cutting-edge treatments and technologies in its field.  Through repair, regeneration and recovery of the brain, spinal cord and musculoskeletal system, RIC advances the ability of its patients to help them to achieve their goals and pursue their life’s passions.  

RIC holds an unparalleled market distinction with a record six federal research designations awarded and funded by the National Institutes of Health (NIH) and the Department of Education’s National Institute of Disability and Rehabilitation Research (NIDRR) in the areas of spinal cord injury, traumatic brain injury, stroke, neurological rehabilitation, outcomes research and rehabilitation engineering research. In fact, the ArmeoSpring has been developed together with researchers and physicians from RIC.

Biomechanical Engineering is a research group of MIRA, the Institute for Biomedical Technology and Technical Medicine of the University of Twente. With its science, MIRA sets standards in the field of new technology for healthcare. Moreover, it brings those new technologies to the market, effectively stimulating change, renewal and progress in clinical applications. MIRA is the only scientific organization in Europe that holds fundamental, applied and clinical chairs.

The ArmeoBoom was developed based on a research prototype developed by scientists of MIRA and in close collaboration with therapists, clinicians and researchers from the Roessingh Research and Development. The aim of the development was to provide a lightweight and movable therapy platform for patients with mild to moderate upper extremity impairments, allowing free movements in a large workspace supported by an arm weight support system with little inertia. In close collaboration between the involved centres, the ArmeoBoom will be clinically tested in a Dutch national multicentre trial.